NCSM Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Rise DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus Pulmonx LUNG Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Edges Higher ZENA Q4 2025 Earnings Significant EPS Miss Amid Surprising Stock Rally TK Q1 2026 Earnings EPS of 055 Highlights Resilient Operations Amid Soft Market ASIX Q1 2026 Earnings Miss on EPS Stock Rises Despite Weakness